These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 10560028)

  • 1. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder.
    Biederman J; Spencer T
    Biol Psychiatry; 1999 Nov; 46(9):1234-42. PubMed ID: 10560028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attention-deficit/hyperactivity disorder: a selective overview.
    Biederman J
    Biol Psychiatry; 2005 Jun; 57(11):1215-20. PubMed ID: 15949990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis.
    Swanson JM; Kinsbourne M; Nigg J; Lanphear B; Stefanatos GA; Volkow N; Taylor E; Casey BJ; Castellanos FX; Wadhwa PD
    Neuropsychol Rev; 2007 Mar; 17(1):39-59. PubMed ID: 17318414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of norepinephrine in the control of activity and attentive processes in animal models of attention deficit hyperactivity disorder.
    Viggiano D; Ruocco LA; Arcieri S; Sadile AG
    Neural Plast; 2004; 11(1-2):133-49. PubMed ID: 15303310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current concepts on the neurobiology of Attention-Deficit/Hyperactivity Disorder.
    Biederman J; Faraone SV
    J Atten Disord; 2002; 6 Suppl 1():S7-16. PubMed ID: 12685515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nature and heritability of attention-deficit/hyperactivity disorder.
    Faraone SV; Doyle AE
    Child Adolesc Psychiatr Clin N Am; 2001 Apr; 10(2):299-316, viii-ix. PubMed ID: 11351800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the alpha-2C-adrenergic receptor gene and attention deficit hyperactivity disorder in a Korean sample.
    Cho SC; Kim JW; Kim BN; Hwang JW; Shin MS; Park M; Kim SA; Cho DY; Yoo HJ; Chung US; Son JW; Park TW
    Neurosci Lett; 2008 Dec; 446(2-3):108-11. PubMed ID: 18835330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurobiology of attention deficit/hyperactivity disorder].
    Purper-Ouakil D; Lepagnol-Bestel AM; Grosbellet E; Gorwood P; Simonneau M
    Med Sci (Paris); 2010 May; 26(5):487-96. PubMed ID: 20510147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies.
    Bonvicini C; Faraone SV; Scassellati C
    Mol Psychiatry; 2016 Jul; 21(7):872-84. PubMed ID: 27217152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of attention deficit hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):77-97. PubMed ID: 10674191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of attention deficit hyperactivity disorder.
    Mick E; Faraone SV
    Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):261-84, vii-viii. PubMed ID: 18295146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Attention deficit hyperactivity disorder (ADHD)--molecular and genetic aspects].
    Migdalska A; Nawara M; Bal J; Mazurczak T
    Med Wieku Rozwoj; 2006; 10(1 Pt 2):343-54. PubMed ID: 17028398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel approach to evaluate central autonomic regulation in attention deficit/hyperactivity disorder (ADHD).
    Sekaninova N; Mestanik M; Mestanikova A; Hamrakova A; Tonhajzerova I
    Physiol Res; 2019 Aug; 68(4):531-545. PubMed ID: 31177787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurobiology of attention-deficit hyperactivity disorder.
    Faraone SV; Biederman J
    Biol Psychiatry; 1998 Nov; 44(10):951-8. PubMed ID: 9821559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder.
    Kim BN; Kim JW; Cummins TD; Bellgrove MA; Hawi Z; Hong SB; Yang YH; Kim HJ; Shin MS; Cho SC; Kim JH; Son JW; Shin YM; Chung US; Han DH
    J Clin Psychopharmacol; 2013 Jun; 33(3):356-62. PubMed ID: 23609393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulant effects in attention deficit hyperactivity disorder: theoretical and empirical issues.
    Denney CB
    J Clin Child Psychol; 2001 Mar; 30(1):98-109. PubMed ID: 11294083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses.
    Genro JP; Kieling C; Rohde LA; Hutz MH
    Expert Rev Neurother; 2010 Apr; 10(4):587-601. PubMed ID: 20367210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genome-wide search for linkage to attention deficit hyperactivity disorder (ADHD) on the X chromosome].
    Jiang SD; He M; Qian YP; Wang DX; Zhang Y; Li F; Tian HJ; Xin RE; Tang GM; Wu XD
    Yi Chuan; 2006 Jan; 28(1):26-30. PubMed ID: 16469712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is emotional dysregulation a component of attention-deficit/hyperactivity disorder (ADHD)?].
    Villemonteix T; Purper-Ouakil D; Romo L
    Encephale; 2015 Apr; 41(2):108-14. PubMed ID: 24703785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder.
    Staller JA; Faraone SV
    Expert Rev Neurother; 2007 Apr; 7(4):351-62. PubMed ID: 17425490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.